Improved radiotherapy for locally advanced Non-Small Cell Lung Carcinoma (NSCLC) patients Research, Nora
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial Research, Nora
